Calculation of new cases of tuberculosis from the consumption of antituberculosis medications; comparison with notification rates.
Theodoracopoulos
P
P
Hellenic Thoracic Research Institute, Athens.
Dimadi
M
M
Constantopoulos
S H
SH
D000995:Antitubercular Agents / Q000627:therapeutic use*; D004363:Drug Utilization; D006115:Greece / Q000453:epidemiology; D006801:Humans; D012293:Rifampin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology*
D000995:Antitubercular Agents; D012293:Rifampin